ao1c07335_si_001.pdf (326.34 kB)
Download fileInterpreting the Pharmacological Mechanisms of Sho-saiko-to on Thyroid Carcinoma through Combining Network Pharmacology and Experimental Evaluation
journal contribution
posted on 2022-03-25, 04:29 authored by Kun Wang, Ruijie Qian, Hongyan Li, Chenyang Wang, Ying Ding, Zairong GaoSho-saiko-to is a
well-known traditional Chinese medicine compound
and is considered to have therapeutic effects against many diseases,
including thyroid cancer (TC). However, the mechanisms and therapeutic
targets of Sho-saiko-to against TC remain unclear. In this study,
network pharmacology, molecular docking, and cell experiments were
combined to predict and verify the targets and mechanisms of the active
ingredients of Sho-saiko-to against TC. The results demonstrated that
the main chemical ingredients of Sho-saiko-to could suppress the viability
and proliferation of TC cells, promote apoptosis through the caspase3
pathway, and induce autophagy through the PI3K-AKT pathway. In addition,
Sho-saiko-to could also induce the redifferentiation of anaplastic
thyroid cancer. Our study provides a novel approach for treating differentiated
thyroid cancer (DTC) or radioactive iodine refractory differentiated
thyroid cancer (RAIR-DTC).
History
Usage metrics
Categories
Keywords
including thyroid canceranaplastic thyroid cancermain chemical ingredientstc remain unclearexperimental evaluation shocould also inducecombining network pharmacologynetwork pharmacologythyroid carcinomainduce autophagycould suppressactive ingredientstherapeutic effectstc cellstc ).results demonstratedpromote apoptosisnovel approachmolecular dockingmany diseasescell experimentscaspase3 pathwayakt pathway